Sampaio Felipe Maurício Soeiro, Wanke Bodo, Freitas Dayvison Francis Saraiva, Coelho Janice Mery Chicarino de Oliveira, Galhardo Maria Clara Gutierrez, Lyra Marcelo Rosandiski, Lourenço Maria Cristina da Silva, Paes Rodrigo de Almeida, do Valle Antonio Carlos Francesconi
National Institute of Infectious Diseases, Oswaldo Cruz Foundation - Rio de Janeiro - Brazil.
PLoS Negl Trop Dis. 2017 Feb 13;11(2):e0005301. doi: 10.1371/journal.pntd.0005301. eCollection 2017 Feb.
Mycetoma is caused by the subcutaneous inoculation of filamentous fungi or aerobic filamentous bacteria that form grains in the tissue. The purpose of this study is to describe the epidemiologic, clinic, laboratory, and therapeutic characteristics of patients with mycetoma at the Oswaldo Cruz Foundation in Rio de Janeiro, Brazil, between 1991 and 2014. Twenty-one cases of mycetoma were included in the study. There was a predominance of male patients (1.3:1) and the average patient age was 46 years. The majority of the cases were from the Southeast region of Brazil and the feet were the most affected anatomical region (80.95%). Eumycetoma prevailed over actinomycetoma (61.9% and 38.1% respectively). Eumycetoma patients had positive cultures in 8 of 13 cases, with isolation of Scedosporium apiospermum species complex (n = 3), Madurella mycetomatis (n = 2) and Acremonium spp. (n = 1). Two cases presented sterile mycelium and five were negative. Six of 8 actinomycetoma cases had cultures that were identified as Nocardia spp. (n = 3), Nocardia brasiliensis (n = 2), and Nocardia asteroides (n = 1). Imaging tests were performed on all but one patients, and bone destruction was identified in 9 cases (42.68%). All eumycetoma cases were treated with itraconazole monotherapy or combined with fluconazole, terbinafine, or amphotericin B. Actinomycetoma cases were treated with sulfamethoxazole plus trimethoprim or combined with cycles of amikacin sulphate. Surgical procedures were performed in 9 (69.2%) eumycetoma and in 3 (37.5%) actinomycetoma cases, with one amputation case in each group. Clinical cure occurred in 11 cases (7 for eumycetoma and 4 for actinomycetoma), and recurrence was documented in 4 of 21 cases. No deaths were recorded during the study. Despite of the scarcity of mycetoma in our institution the cases presented reflect the wide clinical spectrum and difficulties to take care of this neglected disease.
足菌肿是由丝状真菌或需氧丝状细菌经皮下接种于组织中形成颗粒而引起的。本研究旨在描述1991年至2014年期间巴西里约热内卢奥斯瓦尔多·克鲁兹基金会收治的足菌肿患者的流行病学、临床、实验室及治疗特征。该研究纳入了21例足菌肿病例。男性患者居多(1.3:1),患者平均年龄为46岁。大多数病例来自巴西东南部地区,足部是最常受累的解剖部位(80.95%)。真菌性足菌肿多于放线菌性足菌肿(分别为61.9%和38.1%)。真菌性足菌肿患者中,13例中有8例培养结果呈阳性,分离出尖端赛多孢菌复合种(n = 3)、马杜拉足菌肿霉(n = 2)和枝顶孢属(n = 1)。2例出现无菌菌丝,5例为阴性。8例放线菌性足菌肿病例中有6例培养物被鉴定为诺卡菌属(n = 3)、巴西诺卡菌(n = 2)和星形诺卡菌(n = 1)。除1例患者外,所有患者均进行了影像学检查,9例(42.68%)发现有骨质破坏。所有真菌性足菌肿病例均采用伊曲康唑单药治疗或联合氟康唑、特比萘芬或两性霉素B治疗。放线菌性足菌肿病例采用磺胺甲恶唑加甲氧苄啶治疗或联合硫酸阿米卡星周期治疗。9例(69.2%)真菌性足菌肿病例和3例(37.5%)放线菌性足菌肿病例接受了外科手术,每组各有1例截肢病例。11例患者实现临床治愈(真菌性足菌肿7例,放线菌性足菌肿4例),21例中有4例记录有复发情况。研究期间无死亡病例。尽管本机构足菌肿病例较少,但所呈现的病例反映了该病广泛的临床谱以及诊治这种被忽视疾病的困难。